NEWS HIGHLIGHTSMedia Articles Related to Tessalon (Benzonatate)
Whooping Cough Immunity Lasts Longer Than Previously Thought
Source: Immune System / Vaccines News From Medical News Today [2009.11.05]
Immunity to whooping cough lasts at least 30 years on average, much longer than previously thought, according to a new study by researchers based at the University of Michigan and the University of New Mexico. Details are published October 30 in the open-access journal PLoS Pathogens.
Whooping Cough Immunity Lasts 30 Years or More
Source: MedicineNet Pertussis Specialty [2009.11.02]
Title: Whooping Cough Immunity Lasts 30 Years or More
Category: Health News
Created: 10/30/2009 12:10:00 PM
Last Editorial Review: 11/2/2009
Whooping Cough (Pertussis)
Source: MedicineNet Chronic Cough Specialty [2009.08.26]
Title: Whooping Cough (Pertussis)
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/26/2009
Unvaccinated Kids Getting Whooping Cough
Source: MedicineNet Pertussis Specialty [2009.05.26]
Title: Unvaccinated Kids Getting Whooping Cough
Category: Health News
Created: 5/26/2009
Last Editorial Review: 5/26/2009
Cover Your Cough!
Source: MedicineNet Severe Acute Respiratory Syndrome (SARS) Specialty [2008.10.07]
Title: Cover Your Cough!
Category: Health Fact Tool
Created: 11/15/2004
Last Editorial Review: 10/7/2008
Published Studies Related to Tessalon (Benzonatate)
Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough. [2009.06]
Acute cough due to viral upper respiratory tract infection (URI) is the most common form of cough and accounts for tremendous expenditure on prescription and non-prescription cough products worldwide. However, few agents have been shown in properly conducted clinical trials to be effective for cough due to URI...
Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough. [2008.12.31]
Acute cough due to viral upper respiratory tract infection (URI) is the most common form of cough and accounts for tremendous expenditure on prescription and non-prescription cough products worldwide. However, few agents have been shown in properly conducted clinical trials to be effective for cough due to URI...
Benzonatate for opioid-resistant cough in advanced cancer. [1998.01]
Chronic cough is a distressing symptom experienced by approximately 37% of patients with advanced cancer. Palliation of chronic nonproductive cough should always first address the underlying cause but in some patients chronic, nonproductive cough persists and antitussive agents are required... We report three patients with an opioid-resistant cough who achieved symptomatic relief with the peripherally acting nonopioid drug benzonatate.
Benzonatate overdose associated with seizures and arrhythmias. [1998]
CONCLUSION: Seizures and cardiac arrest are possible following an acute ingestion. Quantitative analysis of benzonatate is possible using high-pressure liquid chromatography with tandem mass spectrometry. Routine analysis for benzonatate is not common.
|
